Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis

Clinical and Experimental Immunology

Volumn 128, Issue 2, 2002, Pages 229-237

  Arriaga, A K ^a   Orozco, E H ^a   Aguilar, L D ^a   Rook, G A W ^b   Hernandez Pando R ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cytokines; In situ PCR; Latent tuberculosis

Indexed keywords

BACTERIAL DNA; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL VIRULENCE; BRONCHUS MUCOSA; CELL ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DEATH; DISEASE COURSE; DISEASE MODEL; DNA DETERMINATION; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HISTOLOGY; HYBRID; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LEYDIG CELL; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG GRANULOMA; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MACROPHAGE; MOUSE; MYCOBACTERIUM; NONHUMAN; PATHOLOGY; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; TH1 CELL; TH2 CELL;

EID: 0036097345     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01832.x     Document Type: Article

References (32)

1. Mechanisms of latency in Mycobacterium tuberculosis
2. Tuberculosis: A global overview of the situation today
3. The global tuberculosis situation and the new control strategy of the World Health Organization
4. Dormancy of Mycobacterium tuberculosis and latency of disease
5. Global tuberculosis incidence and mortality during 1990-2000
6. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
7. Exogenous reinfection in tuberculosis
8. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis
9. Persistence of DNA from M. tuberculosis in superficially normal lung tissue during latent infection
10. The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria
11. Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in Balb/c mice
12. Reagent for the single step simultaneous isolation of RNA, DNA and proteins from cells and tissue samples
13. Analysis of the local kinetics and localisation of interleukin 1α, tumour necrosis factor α and transforming growth factor β during the course of experimental pulmonary tuberculosis
14. A mouse model for latent tuberculosis
15. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates
16. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis
17. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis
18. High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested RT-PCR: Correlations with serum IgE levels
19. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities
20. Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy
21. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12
22. Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis
23. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
24. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
25. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
26. Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease
27. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: Establishment of latency and reactivation
28. The role of TNFα in T cell-mediated inflammation depends on the Th1/Th2 cytokine balance
29. IL-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNFα
30. IL-4-regulated enteropathy in an intestinal nematode infection
31. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions
32. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase